Moises Diago

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Chronic Kidney Disease

Hepatitis C Virus Infection

Mesenchymal Stem Cells

Prognostic Factors

Top Venues

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Juan-Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, Adolfo Gallego Moya, Isabel Conde Amiel, Ana Arencibía, Moises Diago, Javier García-Samaniego, Jose Castellote, Susana Llerena, Elisa Rodríguez-Seguel, Beatriz Mateos, Manuel Rodríguez, Jose Miguel Rosales Zabal, Inmaculada Fernández, Jose Luis Calleja, Rosa María Morillas, Silvia Montoliu, Raúl Jesús Andrade, Ester Badia Aranda, Manuel Hernández Guerra, Carlota Jimeno Maté, Jesús M González-Santiago, Beatriz de Cuenca, Vanesa Bernal-Monterde, Manuel Delgado, Juan Turnes Vázquez, Sabela Lens, Maria Buti Ferret
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. Alimentary pharmacology & therapeutics 60 (2) (2024)
Juan-Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, Adolfo Gallego Moya, Isabel Conde Amiel, Ana Arencibía, Moises Diago, Javier García-Samaniego, Jose Castellote, Susana Llerena, Elisa Rodríguez-Seguel, Beatriz Mateos, Manuel Rodríguez, Jose Miguel Rosales Zabal, Inmaculada Fernández, Jose Luis Calleja, Rosa María Morillas, Silvia Montoliu, Raúl Jesús Andrade, Ester Badia Aranda, Manuel Hernández Guerra, Carlota Jimeno Maté, Jesús M González-Santiago, Beatriz de Cuenca, Vanesa Bernal-Monterde, Manuel Delgado, Juan Turnes Vázquez, Sabela Lens, Maria Buti Ferret
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. Alimentary pharmacology & therapeutics 60 (2) (2024)
Juan-Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, Adolfo Gallego Moya, Isabel Conde Amiel, Ana Arencibía, Moises Diago, Javier García-Samaniego, Jose Castellote, Susana Llerena, Elisa Rodríguez-Seguel, Beatriz Mateos, Manuel Rodríguez, Jose Miguel Rosales Zabal, Inmaculada Fernández, Jose Luis Calleja, Rosa María Morillas, Silvia Montoliu, Raúl Jesús Andrade, Ester Badia Aranda, Manuel Hernández Guerra, Carlota Jimeno Maté, Jesús M González-Santiago, Beatriz de Cuenca, Vanesa Bernal-Monterde, Manuel Delgado, Juan Turnes Vázquez, Sabela Lens, Maria Buti Ferret
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. Alimentary pharmacology & therapeutics 60 (2) (2024)
Juan-Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, Adolfo Gallego Moya, Isabel Conde Amiel, Ana Arencibía, Moises Diago, Javier García-Samaniego, Jose Castellote, Susana Llerena, Elisa Rodríguez-Seguel, Beatriz Mateos, Manuel Rodríguez, Jose Miguel Rosales Zabal, Inmaculada Fernández, Jose Luis Calleja, Rosa María Morillas, Silvia Montoliu, Raúl Jesús Andrade, Ester Badia Aranda, Manuel Hernández Guerra, Carlota Jimeno Maté, Jesús M González-Santiago, Beatriz de Cuenca, Vanesa Bernal-Monterde, Manuel Delgado, Juan Turnes Vázquez, Sabela Lens, Maria Buti Ferret
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. Alimentary pharmacology & therapeutics (2024)